Oxford, Horizon Close Up To $20MM Facility for LogicBio

LogicBio Therapeutics closed a $20 million secured debt facility with Oxford Finance and Horizon Technology Finance.

Oxford Finance Extends Regulus Therapeutics Term Loan

Regulus Therapeutics has amended its $14.7 million term loan with Oxford Finance.

Oxford Finance Closes $60MM Facility with RefleXion Medical

Oxford Finance closed a $60 million senior secured term loan with RefleXion Medical. a biotargeting oncology company developing a biology-guided radiotherapy (BgRT) machine for targeted cancer treatment.

Oxford Finance Closes $100MM Facility for Evolus

Evolus has closed on a $100 million senior debt facility with Oxford Finance. An initial tranche of $75 million was funded at closing. $25 million will be available at the company’s option, subject to certain conditions. Cantor Fitzgerald acted as sole lead arranger and financial advisor to Evolus on this transaction.

Oxford Finance Closes $43.3MM Term Loan for CHS

Oxford Finance, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, closed a $43.3 million term loan and line of credit for Continuing Healthcare Solutions.

Oxford Finance Provides $20MM Debt Facility to AliveCor

Specialty finance firm Oxford Finance closed a $20 million senior secured term loan for AliveCor, a privately held company focused on using artificial intelligence to improve cardiac care.

Oxford Finance Closes $25MM Term Loan for Karius

Oxford Finance closed a $25 million senior secured term loan with Karius, a life science company focused on transforming infectious disease diagnostics with genomics.

Oxford Finance Supports Sheridan Investment in Empower PT

Oxford Finance provided debt financing to support Sheridan Capital Partners’ investment in Empower Physical Therapy, a physical therapy practice management company.

Oxford Finance Provides Credit Facility to Unitek Learning

Oxford Finance closed a senior credit facility for Unitek Learning, a portfolio company of Cressey & Company. Oxford served as the sole lender and administrative agent on the transaction.

SVB, Oxford Upsize Reata Pharmaceuticals Facility to $125MM

Reata Pharmaceuticals amended its loan and security agreement with Oxford Finance and Silicon Valley Bank, increasing the term loan facility from $45 million to $125 million.